Curavit Expands Clinical Research Capabilities with Acquisition of Lindus Health CRO Assets, Accelerating Global Trial Execution for Life Science Sponsors

Summary

Curavit Clinical Research has acquired Lindus Health CRO assets to expand clinical research capabilities and accelerate global trial execution. The combined operations will deliver unified U.S. and European trial delivery with faster recruitment across pharma, biotech, medtech, diagnostics, and digital health sectors.